Wells Fargo’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-98,352
| Closed | -$926K | – | 7404 |
|
|
2020
Q3 | $926K | Buy |
98,352
+946
| +1% | +$8.99K | ﹤0.01% | 3923 |
|
|
2020
Q2 | $746K | Sell |
97,406
-5,786
| -6% | -$44.3K | ﹤0.01% | 4046 |
|
|
2020
Q1 | $637K | Buy |
103,192
+42,818
| +71% | +$377K | ﹤0.01% | 3859 |
|
|
2019
Q4 | $735K | Sell |
60,374
-4,524
| -7% | -$49.4K | ﹤0.01% | 4073 |
|
|
2019
Q3 | $750K | Buy |
64,898
+157
| +0.2% | +$1.65K | ﹤0.01% | 4066 |
|
|
2019
Q2 | $647K | Sell |
64,741
-5,625
| -8% | -$60.7K | ﹤0.01% | 4201 |
|
|
2019
Q1 | $907K | Buy |
70,366
+9,604
| +16% | +$143K | ﹤0.01% | 3946 |
|
|
2018
Q4 | $924K | Sell |
60,762
-3,338
| -5% | -$63.6K | ﹤0.01% | 3894 |
|
|
2018
Q3 | $1.28M | Sell |
64,100
-74,930
| -54% | -$1.71M | ﹤0.01% | 3777 |
|
|
2018
Q2 | $2.71M | Sell |
139,030
-20,823
| -13% | -$461K | ﹤0.01% | 3215 |
|
|
2018
Q1 | $3.22M | Buy |
159,853
+98,169
| +159% | +$1.66M | ﹤0.01% | 2983 |
|
|
2017
Q4 | $817K | Buy |
61,684
+10,682
| +21% | +$161K | ﹤0.01% | 4059 |
|
|
2017
Q3 | $941K | Buy |
51,002
+3,010
| +6% | +$56.1K | ﹤0.01% | 3899 |
|
|
2017
Q2 | $883K | Sell |
47,992
-85,545
| -64% | -$1.7M | ﹤0.01% | 3830 |
|
|
2017
Q1 | $3.01M | Buy |
133,537
+1,754
| +1% | +$42K | ﹤0.01% | 2834 |
|
|
2016
Q4 | $4.59M | Buy |
131,783
+56,755
| +76% | +$1.7M | ﹤0.01% | 2480 |
|
|
2016
Q3 | $1.84M | Sell |
75,028
-16,510
| -18% | -$413K | ﹤0.01% | 3038 |
|
|
2016
Q2 | $2.19M | Sell |
91,538
-23,246
| -20% | -$533K | ﹤0.01% | 2904 |
|
|
2016
Q1 | $2.69M | Sell |
114,784
-10,503
| -8% | -$249K | ﹤0.01% | 2708 |
|
|
2015
Q4 | $3.78M | Sell |
125,287
-1,236,221
| -91% | -$39.9M | ﹤0.01% | 2531 |
|
|
2015
Q3 | $54.1M | Sell |
1,361,508
-144,851
| -10% | -$8.99M | 0.02% | 710 |
|
|
2015
Q2 | $104M | Sell |
1,506,359
-160,142
| -10% | -$10.1M | 0.04% | 475 |
|
|
2015
Q1 | $91.1M | Buy |
1,666,501
+679,118
| +69% | +$32.4M | 0.04% | 518 |
|
|
2014
Q4 | $42.1M | Buy |
987,383
+986,374
| +97,758% | +$35.6M | 0.02% | 845 |
|
|
2014
Q3 | $32K | Sell |
1,009
-890
| -47% | -$19K | ﹤0.01% | 5113 |
|
|
2014
Q2 | $39K | Sell |
1,899
-9,026
| -83% | -$167K | ﹤0.01% | 5072 |
|
|
2014
Q1 | $212K | Hold |
10,925
| – | – | ﹤0.01% | 4306 |
|
|
2013
Q4 | $265K | Sell |
10,925
-66
| -0.6% | -$1.55K | ﹤0.01% | 4114 |
|
|
2013
Q3 | $236K | Hold |
10,991
| – | – | ﹤0.01% | 4130 |
|
|
2013
Q2 | $245K | Buy |
+10,991
| New | +$242K | ﹤0.01% | 4045 |
|
Wells Fargo's AMAG Position: Q4 2020 in Review
Wells Fargo sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 98,352 shares — an estimated $926K sold.
Wells Fargo first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $104M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Wells Fargo reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Wells Fargo sold 98,352 AMAG Pharmaceuticals shares in Q4 2020, an estimated $926K.
- Wells Fargo first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Wells Fargo's AMAG Pharmaceuticals position peaked at $104M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.